Ardelyx (ARDX) Enterprise Value (2013 - 2026)
Ardelyx (ARDX) posted Enterprise Value of -$238.1 million for Q1 2026, up 10.06% on a QoQ basis from -$264.7 million in Q4 2025, and down 11.27% year-over-year from -$268.3 million in Q1 2025.
Ardelyx (ARDX) Enterprise Value (2013 - 2026) Analysis & Trends
Ardelyx's Enterprise Value history runs 14 years deep, the most recent figure standing at -$238.1 million for Q1 2026.
- Quarterly Enterprise Value fell 11.27% year-over-year to -$238.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$238.1 million (down 11.27% YoY) and the FY2025 annual result came in at -$264.7 million, down 5.83% from the prior year.
- Enterprise Value was -$238.1 million for Q1 2026 at Ardelyx, up from -$264.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$81.0 million in Q2 2022 and bottomed at -$264.7 million in Q4 2025.
- A 5-year average of -$177.6 million and a median of -$186.0 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 52.85% — and 2023, when it sank 82.16%.
- Ardelyx's Enterprise Value stood at -$123.9 million in 2022, then sank by 48.74% to -$184.3 million in 2023, then slumped by 35.7% to -$250.1 million in 2024, then decreased by 5.83% to -$264.7 million in 2025, then rose by 10.06% to -$238.1 million in 2026.
- Business Quant data shows ARDX's Enterprise Value at -$238.1 million in Q1 2026, -$264.7 million in Q4 2025, and -$242.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -238.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -238.07 Mn |
| Dec 31, 2025 | -264.69 Mn |
| Sep 30, 2025 | -242.71 Mn |
| Jun 30, 2025 | -238.45 Mn |
| Mar 31, 2025 | -213.95 Mn |
| Dec 31, 2024 | -250.10 Mn |
| Sep 30, 2024 | -190.40 Mn |
| Jun 30, 2024 | -185.96 Mn |
| Mar 31, 2024 | -202.58 Mn |
| Dec 31, 2023 | -184.30 Mn |
| Sep 30, 2023 | -165.08 Mn |
| Jun 30, 2023 | -127.58 Mn |
| Mar 31, 2023 | -130.37 Mn |
| Dec 31, 2022 | -123.91 Mn |
| Sep 30, 2022 | -90.62 Mn |
| Jun 30, 2022 | -81.01 Mn |
| Mar 31, 2022 | -89.70 Mn |
| Dec 31, 2021 | -116.69 Mn |
| Sep 30, 2021 | -141.65 Mn |
| Jun 30, 2021 | -171.81 Mn |